AKI Therapeutics
AKI Therapeutics A/S is a preclinical biotechnological company that focuses 100% on developing an effective, specific treatment for acute kidney injury. The company’s drug candidate is a pioneering concept within this treatment area, which presents one of the biggest and most important challenges in the field of current intensive medical care, to which there are currently no alternative treatments.
Mission
To become a revolutionary treatment providing company for people suffering from acute kidney injury.
Vision
AKI Therapeutics will endeavour to provide treatments for acute kidney injury and make it widely available to all patients in a cost effective manner.
Business model
Through its platform, AKI Therapeutics will seek to obtain a scientific and relevant clinical “proof-of-concept” for the company’s drug candidate for the treatment of AKI.
